Is LASIK in China safe? Check, don't trust
Platforms, volumes & regulation at partner refractive centers · Researched July 2026 · Published August 2026
"Is it safe?" is really three questions: is the equipment the same, is the care competent, and what happens if something goes wrong. This page answers each with facts you can verify — the device names to ask for, what surgical volume does and doesn't buy you, and how hospital-based refractive care is structured — instead of asking you to take a sales page's word for it. The one thing no country changes: refractive surgery has real risks everywhere, and the decision that actually protects you is the diagnostic workup, made by the operating surgeon.
Question one: is the equipment the same?
Yes — and this is checkable, not a claim. Refractive lasers are built by a handful of global manufacturers, and a machine does not get configured to a lower standard for one market. The platform behind each procedure is the same product wherever it is installed:
| Procedure | Platform | Who makes it | The check |
|---|---|---|---|
| SMILE | VisuMax femtosecond laser | ZEISS (Germany) | SMILE only exists on ZEISS platforms — there is no off-brand version to be given |
| Femto-LASIK | Femtosecond + excimer pairing (e.g. WaveLight, MEL/VisuMax combinations) | Alcon (US/CH), ZEISS | Ask which femtosecond laser cuts the flap and which excimer does the ablation — a real center answers with model names |
| TransPRK | Surface-ablation excimer (e.g. Amaris) | SCHWIND (Germany) | Single-step "no-touch" TransPRK is a specific platform capability, not a technique any laser can do |
| EVO ICL | EVO/EVO+ Visian ICL lens | STAAR Surgical (US) | Every genuine ICL is made by one company; the lens implanted in Shanghai and the lens implanted in Los Angeles leave the same factory line |
Platform families in use at partner refractive centers, researched July 2026. Specific installed models vary by hospital and are confirmed in writing during scheduling — asking for them is normal, and the answer arriving quickly is itself a good sign.
These same platforms hold the relevant Western approvals in their home markets — SMILE on VisuMax and the EVO ICL are both FDA-approved in the United States — and in China each device must be registered with the NMPA, the national medical products regulator, before clinical use. The physics of your surgery does not know what country it is in.
Question two: is the care competent?
Here the honest answer favors China more than most first-time readers expect, for one structural reason: volume. China has the world's largest myopic population and concentrates refractive surgery in high-throughput hospital departments and national ophthalmic chains. The result, as the SMILE cost guide covers from the price angle, is that China performs more SMILE than the rest of the world combined, and the busiest Chinese refractive surgeons log annual case counts most Western practices would need many years to accumulate. Volume is not a guarantee of skill — but surgeon experience correlating with refined technique and complication management is one of the better-documented patterns in surgery, and it is the real engine behind both the quality and the hospital-scale pricing.
The second structural point: partner care is hospital-based. Refractive surgery in China grew up inside ophthalmology departments of large tertiary hospitals (the national tier system's top grade, colloquially "3A") and specialist eye hospitals, rather than in standalone laser storefronts. Practically, that means your surgery happens in a building with a full ophthalmology service behind it — retina, cornea, glaucoma — so the rare finding that needs a different specialist is a referral down a corridor, not a scramble. (For non-refractive eye surgery in China — cataract, glaucoma, retina — see our sister resource at eyesurgerychina.com; this site deliberately covers vision correction only.)
Question three: what are the actual risks?
The same ones as everywhere, and a page that lists them plainly is doing more for your safety than a page that promises you'll be fine. Common and usually temporary: dry eye in the early months, night glare and halos while healing settles. Uncommon: residual prescription needing an enhancement, LASIK flap-related issues. Rare and serious: infection, corneal ectasia after laser surgery on the wrong cornea, and for ICL — cataract formation, pressure rise, or long-term endothelial cell decline, which is why ICL carries an annual monitoring schedule for life. Screening exists to keep the wrong eyes out of surgery: the workup's tomography, pachymetry, and endothelial imaging are hunting for exactly the corneas and anterior chambers that turn a routine procedure into a risky one. That is why the workup — not the country — is the main safety event of the whole trip, and why the candidacy guide is the most important page on this site.
What safety actually turns on — anywhere
- Screening rigor. A center that measures more and declines more is safer than a center that says yes quickly — roughly one in five inquiries here ends up matched to a different procedure than the one asked about, and some to none. Diagnostics happen on day one, before surgery is confirmed; a surgeon who has reasons to say no is the product.
- Surgeon judgment on the margin. Thin corneas, suspicious topography, very high prescriptions — the cases in the options-map guide — are where centers differ. The question "what would rule me out?" tells you more about a provider than any before/after gallery.
- Aftercare structure. Records in English, a named contact channel, and a written enhancement policy — the fine-print page covers what to demand. A complication handled well is a safety property; a complication handled by an info@ inbox is not.
Questions people actually ask
Is LASIK in China safe?
The equipment is the same global platforms (ZEISS, Alcon, SCHWIND, STAAR), volumes at the big centers are the world's highest, and care is hospital-based. Risks are the same as anywhere — safety turns on screening and surgeon judgment, verified case by case.
Are the lasers the same as in Western clinics?
Same manufacturers, same models — SMILE only exists on ZEISS VisuMax, and every EVO ICL comes from STAAR Surgical. Ask any center for its device model names; a real one answers in writing.
Who regulates this?
Devices are registered with the NMPA before clinical use; hospitals are licensed and tiered nationally; surgeons are licensed ophthalmologists. Regulation is the floor — screening rigor is the ceiling, and that you verify per center.
What's the biggest real risk?
Having surgery on eyes that shouldn't have it. The rare serious complications cluster in poorly screened cases, which is why the day-one diagnostic workup is the main safety event and the surgeon's right to say no is your best protection.
Does high volume mean rushed care?
Throughput is high by Western standards — that's the model, and it's what the pricing reflects. The parts that shouldn't be fast are the workup and the consent conversation; if either feels rushed at any center, in any country, walk.